Diazepam binding inhibitor is a potent cholecystokinin-releasing peptide in the intestine.
Pancreatic proteases in the duodenum inhibit the release of cholecystokinin (CCK) and thus exert feedback control of pancreatic exocrine secretion. Exclusion of proteases from the duodenum either by the diversion of bile-pancreatic juice or by the addition of protease inhibitors stimulates exocrine...
Na minha lista:
| Publicado no: | Proc Natl Acad Sci U S A |
|---|---|
| Principais autores: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
National Academy of Sciences
1996
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC38851/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8755579/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.93.15.7927 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
